UroToday22h
ASTRO 2024: Role of ADT and Genomic Risk Stratification for Patients with Unfavorable Intermediate-Risk Prostate Cancer
(UroToday.com) The 2024 American Society for Radiation Oncology (ASTRO) annual meeting held in Washington D.C., between September 29 and October 2 was host to the session EDU 16 - Management of ...
UroToday22h
ASTRO 2024: SBRT for Unfavorable Intermediate-Risk Prostate Cancer
(UroToday.com) The 2024 American Society for Radiation Oncology (ASTRO) annual meeting held in Washington D.C., between September 29 and October 2 was host to the session EDU 16 - Management of ...
UroToday3d
ASTRO 2024: Pathologic Features of Small Cell Variants of the Genitourinary Tract
(UroToday.com) The 2024 ASTRO annual meeting included a session on the management of small cell neuroendocrine tumors of the genitourinary tract, featuring a presentation by Dr. Hikmat Al-Ahmadie ...
UroToday3d
Navigating Cancer Care Costs Videos
A Complex Landscape of Out-of-Pocket Expenses - Benjamin Pockros ...
UroToday4d
The Role of Whole-Gland and Focal Cryotherapy in Recurrent Prostate Cancer.
Prostate cancer is the most common non-cutaneous malignancy in men, with the majority of newly diagnosed patients eligible for active surveillance. Despite definitive treatment, a considerable ...
UroToday4d
A urine-based liquid biopsy for detection of upper tract urothelial carcinoma: a self-matched study.
To establish the pathological diagnosis of UTUC before treatment is profitable. At present, the conventional pathological diagnostic methods have certain problems. Besides, the urine-based DNA ...
UroToday4d
Partial prostatectomy for localized prostate cancer.
Localized prostate cancer treatment aims to balance cancer control with preserving urinary and erectile function. While focal ablative therapies have emerged, their uncertain prognosis prompts ...
UroToday4d
Prognostic Nomogram, Demographics and Comparative Analysis of Urinary Bladder Small Cell and Large Cell Neuroendocrine Carcinoma.
This retrospective study aims to provide a comprehensive analysis of the demographics, survival rates, and therapeutic approaches of small-cell neuroendocrine carcinoma (SCNEC) and large-cell ...
UroToday4d
Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients.
Current guidelines endorse the use of perioperative chemotherapy (POC) in muscle-invasive bladder cancer (MIBC) to enhance the long-term overall survival (OS) compared to radical cystectomy (RC) alone ...
UroToday4d
Factors that Affect Outcome of Ultrasound-Guided Radiofrequency Ablation of Renal Masses.
The purpose of this study was to examine the factors influencing the efficacy and safety of the ultrasound-guided radiofrequency ablation of renal tumors. Between January 2010 and December 2018, 159 ...
UroToday4d
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2).
Unfortunately, not all metastatic castration-resistant prostate cancer (mCRPC) patients receive available life-prolonging systemic therapies, emphasizing the need to optimize mCRPC treatment ...